Mortality among confirmed Lassa Fever cases in Ondo State, Nigeria, January 2017- March 2019: A cross sectional study

O S Ilesanmi, O. Ayodeji, N. Adedosu, O. Ojo, C. Abejegah, T. Jegede, T. T. Adebayo, Isiaka A. Ayeni, L. Olatunde, L. Ahmed
{"title":"Mortality among confirmed Lassa Fever cases in Ondo State, Nigeria, January 2017- March 2019: A cross sectional study","authors":"O S Ilesanmi, O. Ayodeji, N. Adedosu, O. Ojo, C. Abejegah, T. Jegede, T. T. Adebayo, Isiaka A. Ayeni, L. Olatunde, L. Ahmed","doi":"10.18502/jchr.v11i1.9090","DOIUrl":null,"url":null,"abstract":"Background: Lassa fever (LF) is an acute viral haemorrhagic disease endemic in Ondo State, Nigeria. This study aimed to determine the factors associated with mortality among confirmed LF cases. \nMethods: A cross sectional study design was used by conducting a retrospective review of the records of all patients who had been treated for LF at the Federal Medical Centre, Owo since 2017 till March 2019. Descriptive statistics were done, case fatality rate was calculated. Chi square tests were used to explore associations. Logistic regression was used to identify the predictors of death. Data were analysed with SPSS version 23.0. P values ≤0.05 were statistically significant. \nResults: The median age was 34 years, and the inter-quartile range was 24-48 years. A total of 30 deaths (case fatality rate [CFR] = 10.9%) were recorded, of which 24 (15.5%) were males. Also, the fatality rate increased from 1.6% in 2017 to 10.5% in 2018 and 16.7% in 2019. During peak period, mortality recorded was 15(8.5%) and non-peak periods (April to December), 14(14.9%) was recorded (p=0.104). Fatality was 12.5% (1 out of 8) among pregnant women with 100% foetal death. Patients aged 18-45 years had 0.25 odds of dying (AOR = 0.25; 95%CI= 0.08, 0.76) compared to those aged ≥ 46 years. Those who commenced ribavirin ≥7 days (AOR 4.1; CI = 1.06, 15.42) and those with elevated urea level (AOR 7.5; CI = 2.5, 23.1) have more odds of dying. \nConclusions: A well-coordinated LF outbreak response is needed both at LF peak non-peak periods.","PeriodicalId":15521,"journal":{"name":"Journal of Community Health Research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Community Health Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/jchr.v11i1.9090","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Lassa fever (LF) is an acute viral haemorrhagic disease endemic in Ondo State, Nigeria. This study aimed to determine the factors associated with mortality among confirmed LF cases. Methods: A cross sectional study design was used by conducting a retrospective review of the records of all patients who had been treated for LF at the Federal Medical Centre, Owo since 2017 till March 2019. Descriptive statistics were done, case fatality rate was calculated. Chi square tests were used to explore associations. Logistic regression was used to identify the predictors of death. Data were analysed with SPSS version 23.0. P values ≤0.05 were statistically significant. Results: The median age was 34 years, and the inter-quartile range was 24-48 years. A total of 30 deaths (case fatality rate [CFR] = 10.9%) were recorded, of which 24 (15.5%) were males. Also, the fatality rate increased from 1.6% in 2017 to 10.5% in 2018 and 16.7% in 2019. During peak period, mortality recorded was 15(8.5%) and non-peak periods (April to December), 14(14.9%) was recorded (p=0.104). Fatality was 12.5% (1 out of 8) among pregnant women with 100% foetal death. Patients aged 18-45 years had 0.25 odds of dying (AOR = 0.25; 95%CI= 0.08, 0.76) compared to those aged ≥ 46 years. Those who commenced ribavirin ≥7 days (AOR 4.1; CI = 1.06, 15.42) and those with elevated urea level (AOR 7.5; CI = 2.5, 23.1) have more odds of dying. Conclusions: A well-coordinated LF outbreak response is needed both at LF peak non-peak periods.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2017年1月至2019年3月,尼日利亚翁多州武装拉沙热病例的死亡率:一项横断面研究
背景:拉沙热是尼日利亚翁多州流行的一种急性病毒性出血性疾病。本研究旨在确定与LF确诊病例死亡率相关的因素。方法:采用横断面研究设计,对自2017年至2019年3月在奥沃联邦医疗中心接受过LF治疗的所有患者的记录进行回顾性研究。进行描述性统计,计算病死率。卡方检验用于探究关联。采用Logistic回归确定死亡预测因素。数据采用SPSS 23.0进行分析。P值≤0.05有统计学意义。结果:年龄中位数为34岁,四分位数间距为24 ~ 48岁。共报告死亡30例(病死率[CFR] = 10.9%),其中男性24例(15.5%)。此外,死亡率从2017年的1.6%上升到2018年的10.5%和2019年的16.7%。高峰期死亡15例(8.5%),非高峰期(4 ~ 12月)死亡14例(14.9%)(p=0.104)。死亡率为12.5%(1 / 8),胎儿死亡率为100%。18-45岁患者的死亡几率为0.25 (AOR = 0.25;95%CI= 0.08, 0.76),与≥46岁的患者相比。开始使用利巴韦林≥7天的患者(AOR 4.1;CI = 1.06, 15.42)和尿素水平升高组(AOR为7.5;CI = 2.5, 23.1)的患者死亡几率更高。结论:在疫情高峰和非高峰期间,都需要协调良好的疫情应对措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
39
审稿时长
8 weeks
期刊最新文献
Predictors of the Intention to Perform Preventive Behaviors Against the Occurrence of Breast Cancer Recognizing and Describing the Factors Affecting the Design of the Innovation Ecosystem Model in the Field of Health with an Emphasis on the Role of E-Government Institutionalization of Sports for All in Iranian Families Cross-Cultural Adaptation, Reliability and Validity of the Persian Version of COVID-19 Preventive Measures Questionnaire in Radiation Therapy Center, Yazd, Iran Survival Analysis of Ovarian Cancer Patients in Yazd City, Central part of Iran, 1999-2018
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1